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Abstract
Introduction: The MSIS-29 was developed to assess the physical and psychological impact of MS. The aims of this study
were to use the responses to the MSIS-29 via the web portal of the UK MS Register to: examine the internal properties of the
scale delivered via the internet, profile the cohort, and assess how well the scale measures impact of disability on the
potential workforce.
Methods: Between May 2011 and April 2012, 4558 people with MS completed the MSIS-29(v.1). The responses were collated
with basic demographic and descriptive MS data and the resulting dataset was analysed in SPSS(v.20).
Results: Internal consistency was high (Cronbach’s alpha 0.97 MSIS-29-PHYS, 0.92 MSIS-29-PSYCH). The mean MSIS-29-PHYS
score was 60.5 (50.6%) with a median of 62 and the mean MSIS-29-PSYCH score was 24.8 (43.8%) with a median of 24.
Physical scores increased with age and disease duration (p,0.001, p,0.001), but there was a weak negative relationship
between psychological scores and age (p,0.001). The odds of people having an employment status of sick/disabled were
7.2 (CI 5.5, 9.4, p,0.001) for people with a moderate physical score, and 22.3 (CI 17.0, 29.3, p,0.001) for people with a high
physical score (relative to having a low physical score).
Conclusions: This largest known study of its kind has demonstrated how the MSIS-29 can be administered via the internet
to characterise a cohort, and to predict the likely impact of disability on taking an active part in the workforce, as a
reasonable proxy for the effects of MS on general activities. The findings examining MSIS-29-PHYS and MSIS-29-PSYCH
scores against age support the use of two sub-scales, not a combined score. These results underline the importance of using
a scale such as this to monitor disability levels regularly in guiding MS care to enable people to be as active as possible.
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Introduction
Multiple Sclerosis (MS) is a chronic, inflammatory, autoimmune
condition, well-known for resulting in physical and cognitive
disabilities over the disease course. It is important to be able to
assess the impact of any chronic disease and often general tools are
used (such as the Hospital Anxiety and Depression Scale (HADS)
[1] in conjunction with instruments designed for the disease type.
The Multiple Sclerosis Impact Scale (MSIS-29) was developed as
such a disease-specific instrument to assess the physical and
psychological impact of living with MS [2]. It consists of 29
questions divided into two components: a physical scale (MSIS-29-
PHYS) of 20 questions, and a psychological scale (MSIS-29-
PSYCH) of 9 questions. The responses are scored on a Likert scale
(1–5, version 1) and summed to give a maximum of 100 on MSIS-
29-PHYS and 45 on MSIS-29-PSYCH. These raw scores can be
transformed to create two scales each spanning 0 to 100 and
expressed as percentages [2,3]. The MSIS-29 scale has been
subjected to rigorous evaluations to demonstrate its validity,
reliability and psychometric properties [2–4], its suitability for
assessing people with MS in comparison with other established
measures, and for proxy use with partners of people with MS [5–
9]. As a result, it is reported to be a valid and reliable method of
assessing quality of life and is increasingly being used in MS
research and clinical settings [3–5,10].
The UK MS Register aims to address the need for an increased
knowledge-base about MS by bringing together datasets from
multiple sources to create a rich resource for research, policy
development and service planning. It has been designed to capture
data from three main sources, with the ability to anonymously link
these data at the individual level whilst retaining privacy [11,12].
Data are collected directly from people with MS via a purpose-
built web portal, from sources of routine administrative data, and
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from clinical information systems operating in NHS neurology
clinics. The web portal was launched in May 2011 and, by April
2012, 8736 people with MS had enrolled, with further data
collection underway as a continual process. Data acquisition from
clinics and administrative sources is underway, subject to consent
and data availability. In bringing together data from three
disparate sources the UK MS Register model is innovative in its
design and provides new opportunities for studying MS via linked
data. The Register is based on the proven technologies and robust
Information Governance arrangements in place in the Secure
Anonymised Information Linkage (SAIL) system developed by the
Health Information Research Unit (HIRU) [13,14].
The web portal acts as a questionnaire delivery platform so that
people with MS can provide information on their experiences of
living with MS. It hosts a number of validated questionnaires,
including: the Hospital Anxiety and Depression Scale (HADS) [1],
the EQ-5D [15] and the MS Disease Impact Scale-29 (MSIS-29)
[2]. These cover a range of topics such as: MS and mental well-
being; impact of MS on daily life; lifestyle and health outcomes.
Baseline information including: age, gender, date of diagnosis of
MS, type of MS, age at onset and employment status is collected as
part of the registration process and a questionnaire entitled ‘You,
your MS and lifestyle’ [11]. We have shown that it is feasible to
collect information in this way and to use it to characterize a
cohort of people with MS, and to study the mental well-being of
people with MS via the HADS [11,16]. Responses gained via the
web portal provided the opportunity for the largest known study of
the physical and psychological impacts of MS using the MSIS-29.
Research aim
In their development and validation work on the MSIS-29,
Hobart and colleagues [2,3] recommended that the scale should
be used in different settings, and so we sought to examine its
internal properties when delivered via the internet and to compare
them with published findings. We then set out to profile and
characterise our cohort of people with MS using descriptive
statistics. There were two main reasons for this: firstly, this is the
first paper from the UK MS Register that uses the MSIS-29
responses, and we wanted to describe this cohort for researchers
who may wish to use Register data in the future; and, secondly,
since it is a large cohort we believe the findings will be of interest
for comparative purposes with other studies that may not have
access to such large numbers. Furthermore, since the MSIS-29 is
designed to measure disability, and we collect data on the
employment status of people with MS, we sought to find out the
extent to which the scores translate into, and predict, an
employment status of sick/disabled. This would show how well
the scale can be used to measure the impact of disability on the
potential workforce, which may also act as a reasonable proxy for
impact on general life activities.
Methods
Research ethics and governance
The UK MS Register study was peer-reviewed via the MS
Society and it received ethical approval from the South West –
Central Bristol Research Ethics Committee (11/SW/0160) as a
research database [17]. Under this ethical approval, data collected
via the portal, the neurology clinics and routine administrative
sources can be anonymously linked using the SAIL methodologies
provided that agreement to the portal terms of service (via the
portal) and written informed participant consent (at the clinics)
have been obtained. The working UK MS Register contains only
anonymous data but facilities are in place to re-contact partici-
pants to take part in further research [18]. In future, the Register
data will be made accessible for analysis by researchers external to
the team, subject to regulatory and governance requirements. The
final operating model for these arrangements is yet to be
determined, but we are able at accommodate researcher requests
to view the data in the interim, subject to any necessary
amendments to regulatory and governance approvals and a non-
disclosure agreement.
Data collection and analysis
Adults with MS living in the UK have been able to enrol on the
web portal of the UK MS Register since its launch in May 2011.
Up to April 2012 we received 4558 complete responses to the
MSIS-29 (version 1) via the web portal. These were collated with
basic demographic, descriptive MS data and employment status
and the resulting dataset was analysed in SPSS (v.20). Raw scores
(physical: 20 to 100, psychological: 9 to 45) and transformed scores
(%) were both used for ease of reference, and the physical (MSIS-
29-PHYS) and psychological (MSIS-29-PSYCH) scores were
treated as separate sub-scales in all the analyses in accordance
with the suggested guidance of Hobart and colleagues [2,3].
Descriptive statistics were used to characterize the cohort of people
with MS. Cronbach’s alpha was used to assess the internal
consistency of MSIS-29-PHYS and MSIS-29-PSYCH. Frequen-
cies were studied by categorising the physical and psychological
scales into tertiles with thresholds of 33.3%, 66.7% and 100% to
represent low, moderate and high scores, respectively, and chi
squared tests were used to assess goodness of fit. The continuous
variables were assessed for normality using the Kolmogorov-
Smirnov test and all were found to deviate significantly from the
normal distribution (p,0.001). Because of this, non-parametric
inferential tests were used: Spearman’s rank correlation coefficient
to measure relationships between variables, the Mann-Whitney U
test was used to assess differences between two independent
samples, and the Kruskal-Wallis one-way analysis of variance was
used to compare more than two independent samples. Logistic
regression was used to predict the outcome of categorical variables
using the tertiles for MSIS-29-PHYS and MSIS-29-PSYCH, and
the raw MSIS-29-PHYS scores in bands of 10 (above the
minimum score of 20).
Results
Internal consistency and correlation
The properties of the MSIS-29 have been demonstrated, and
we have been able to show similarly good results using our data
obtained via the web portal [2–5,7] The internal consistency of the
MSIS-29-PHYS and MSIS-29-PSYCH question scores were
assessed using Cronbach’s alpha and were found to be 0.97 and
0.92 respectively. There was a fairly strong positive relationship
between the MSIS-29-PHYS and MSIS-29-PSYCH scores
(rho=0.60, p,0.001). The mean MSIS-29-PHYS and MSIS-29-
PSYCH scores were around the middle of the scales (Table 1) and
the floor and ceiling effects were negligible (1.3% of respondents
were at scale minimum and 1.2% at scale maximum for MSIS-29-
PHYS, 1.6% were at scale minimum and 1.0% at scale maximum
for MSIS-29-PSYCH).
Characteristics of respondents
There were 28.7% men and 70.9% women in the sample and
0.4% did not record their gender (N=4558). The types of MS
were: 14.8% primary progressive MS (PPMS), 62.1% relapsing-
remitting MS (RRMS), 8.1% secondary progressive MS (SPMS)
and 15.1% did not know their type of MS (DKMS) (N= 4462).
Impact of MS - MSIS-29 - UK MS Register
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The mean age of the respondents was 50.7 years (SE 0.17, SD
11.2) with a median of 51 years (IQR 16). The mean time since
diagnosis (by a neurologist) was 10.9 years (SE 0.15, SD 8.9) with a
median of 9 years (IQR 12). The mean raw MSIS-29-PHYS score
was 60.5 (SE 0.32, SD 21.6) which equates to 50.6%, with a
median of 62 (IQR 35). The mean raw MSIS-29-PSYCH score
was 24.8 (SE 0.13, SD 8.9) which equates to 43.8%, with a median
of 24 (IQR 14). Fuller details are given in Table 1, including values
by gender and type of MS.
Relationships between continuous variables
There was a weak positive relationship between MSIS-29-
PHYS and age (rho=0.21, p,0.001) and a similar relationship
with time since diagnosis (rho=0.24, p,0.001). However, there
was a weak negative relationship between MSIS-29-PSYCH and
age (rho=20.10, p,0.001) and little or no relationship with time
since diagnosis (rho=20.03, not sig). This confirms the guidance
to use the scales separately and not combined as a single score, as
otherwise differential effects on physical and psychological well-
being could be masked [2].
Frequencies of physical and psychological impact
The physical and psychological scales were divided into tertiles
to represent low, moderate and high scores in order to study
frequencies. There were just over 30% of people in each tertile for
MSIS-29-PHYS, and approximately 40% with a low score, 40%
with a moderate score and 19% with a high score for MSIS-29-
PSYCH (Table 2). The proportions of people in each tertile were
assessed based on their type of MS. For MSIS-29-PHYS it was
found that the largest proportion of people with PPMS were in the
high tertile (45.2%), and similarly for those with SPMS (51.7%),
whereas for the people with RRMS, the largest group was in the
low tertile (37.4%). The proportion of people who did not know
their type of MS (DKMS) was greatest in the moderate tertile
(37.4%) with almost equal proportions in the low and high tertiles
(Table 2) (chi squared p,0.001). The patterns within the tertiles
for MSIS-29-PSYCH were fairly similar among the MS types, but
with slightly higher proportions of people with SPMS in the
moderate and high tertiles (Table 2), however this was not
statistically significant. The relationship between the scales was
again shown by comparing the low, moderate and high tertiles of
the MSIS-29-PHYS and MSIS-29-PSYCH scores. It can be seen
that 55.0% of respondents who have a low MSIS-29-PHYS score
also have a low MSIS-29-PSYCH score, 45.6% with a moderate
MSIS-29-PHYS score have a moderate MSIS-29-PSYCH score,
and 66.6% of the people with a high MSIS-29-PHYS score also
fall into the high tertile on MSIS-29-PSYCH. The converse was
also evident with notably smaller proportions of respondents
Table 1. Timelines and MSIS-29 scores of the cohort.
Categories N Mean SD SE Median IQR Range
Age (yrs):
All 4547 50.7 11.2 0.17 51.0 16 20 to 87
Male 1310 52.8 11.4 0.31 53.0 17 23 to 87
Female 3229 50.5 11.4 0.20 50.0 16 20 to 84
Time from first
symptoms (yrs):
All 3624 16.3 11.2 0.19 14.0 16 0 to 63
Male 1039 16.5 11.3 0.35 14.0 16 0 to 62
Female 2567 16.2 11.2 0.22 14.0 16 0 to 63
Time since diagnosis
(yrs):
All 3606 10.9 8.9 0.15 9.0 12 0 to 64
Male 1031 11.3 8.9 0.28 10.0 13 0 to 48
Female 2557 10.8 8.9 0.18 9.0 12 0 to 64
MSIS-29-PHYS score
(raw):
All 4558 60.5 21.6 0.32 62.0 35 20 to 100
PPMS 659 70.0 17.9 0.70 72.0 27 22 to 100
RRMS 2769 56.7 21.9 0.42 57.0 37 20 to 100
SPMS 362 73.6 16.0 0.84 74.0 22 28 to 100
DKMS 672 59.3 21.2 0.82 61.5 36 20 to 100
MSIS-29-PHYS score
(%):
All 4558 50.6 27.0 0.40 52.5 44 0 to 100
PPMS 659 62.5 22.4 0.87 65.0 34 3 to 100
RRMS 2769 45.9 27.3 0.52 46.3 46 0 to 100
SPMS 362 67.0 20.0 1.05 67.5 28 10 to 100
DKMS 672 49.1 26.5 1.02 51.9 45 0 to 100
MSIS-29-PSYCH score
(raw):
All 4558 24.8 8.9 0.13 24.0 14 9 to 45
PPMS 659 24.7 8.6 0.33 24.0 13 9 to 45
RRMS 2769 24.7 9.0 0.17 24.0 14 9 to 45
SPMS 362 26.1 8.7 0.46 25.0 13 9 to 45
DKMS 672 24.4 9.3 0.36 24.0 14 9 to 45
MSIS-29-PSYCH score
(%):
All 4558 43.8 24.8 0.37 41.7 39 0 to 100
PPMS 659 43.5 23.9 0.93 41.7 36 0 to 100
RRMS 2769 43.5 24.9 0.47 41.7 39 0 to 100
SPMS 362 47.5 24.1 1.27 44.4 36 0 to 100
DKMS 672 42.9 25.7 1.00 41.7 39 0 to 100
Descriptions of the variables are shown. Slight differences in totals within
categories compared to all are due to the small percentages (,2%) of
participants for whom either age, gender or type of MS was missing.
doi:10.1371/journal.pone.0055422.t001
Figure 1. Proportions of respondents with low moderate and
high MSIS-29-PHYS and MSIS-29-PSYCH scores. The scores were
divided into tertiles: low moderate and high, and the proportions of
respondents in each tertile for MSIS-29-PHYS and MSIS-29-PSYCH were
compared.
doi:10.1371/journal.pone.0055422.g001
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having a low score on one scale and a high score on the other
(Figure 1) (chi squared p,0.001).
Physical and psychological impact by MS type
Kruskall-Wallis tests were used to examine how the MSIS-29-
PHYS and MSIS-29-PSYCH scores varied by type of MS. It was
found that MSIS-29-PHYS scores were higher in progressive types
of MS compared to RRMS, and were highest in SPMS (p,0.001,
N=4462). MSIS-29-PSYCH scores were also highest in SPMS
(p=0.03, N=4462). The measures of spread and central tendency
are shown in Table 1 and the patterns are illustrated in Figures 2
and 3.
Impact on the potential workforce
The potential workforce was taken as men of ages ,=64 years
and women ,=59 years [19]. The respondents provided
information on their employment status. Of the potential
workforce (N= 3538), 47.6% were in paid employment, 31.3%
were sick/disabled, 9.8% were retired, 4.4% were looking after
family, 3.6% were unemployed, and the remainder were divided
among voluntary work (1.2%) in education (0.6%) or gave other/
not applicable as their response (1.5%). By comparison, 76.9% of
the general UK potential workforce) are economically active, and
24.5% are recorded as being sick/disabled [19]. The mean MSIS-
29-PHYS raw score for the people who stated they were sick/
disabled was 75.0 (SE 0.48, SD 16.0, median 77) equating to
68.7%; for the rest of the potential workforce it was 52.3 (SE 0.42,
SD 20.7, median 51) equating to 40.4% and, using a Mann
Whitney U test, this difference was found to be statistically
significant (p,0.001, N=3538). MSIS-29-PSYCH scores also
differed between those who were sick/disabled and those who
were not. The mean MSIS-29-PSYCH raw score for the sick and
disabled was 29.1 (SE 0.26, SD 8.5, median 29) equating to 55.7%
and for the rest of the potential workforce it was 23.6 (SE 0.18, SD
8.7, median 23) equating to 40.5% (p,0.001, N=3538). These
results are shown in Figures 4 and 5.
Logistic regression was used to assess how predictive of sick/
disabled status the MSIS-29-PHYS and MSIS-29-PSYCH scores
were. This was conducted firstly using the tertiles of low, moderate
and high MSIS-29-PHYS scores. It was found that, relative to the
low tertile, people with a moderate MSIS-29-PHYS score had
odds of 7.2 (CI 5.5, 9.4, p,0.001) of being sick/disabled, and for
the people with a high score the odds were 22.3 (CI 17.0, 29.3,
p,0.001). Using the same method for the MSIS-29-PSYCH
tertiles the values were 2.3 (CI 2.0, 2.8, p,0.001) and 4.3 (CI 3.5,
5.2, p,0.001), respectively. Since there was a large difference in
the means of the MSIS-29-PHYS scores, and the odds ratios were
relatively high, further logistic regression was carried out using the
raw MSIS-29-PHYS scores in bands of 10 (above the minimum
score of 20). The resulting odds ratios (relative to the lowest band
of scores up to 30) were plotted against the bands and shown in
Figure 6. Confidence intervals are also shown and all p values were
p,0.001. It can be seen that there is a clear rise in the odds of
being sick/disabled as the scores increase.
There may be many reasons why a person is or is not actually
engaged in gainful employment, but it was found that the MSIS-
29-PHYS and MSIS-29-PSYCH scores were significantly lower
among those in work compared to the remainder of the cohort.
The MSIS-29-PHYS scores of people in work showed a mean of
48.2 (SE 0.48, SD 19.7, median 46) (35.3%) compared to 69.5 (SE
0.44, SD 18.9, median 72) (61.9%) for those not in paid work. For
the MSIS-29-PSYCH the values were 22.8 (SE 0.21, SD 8.6,
median 22) (38.4%) and 27.5 (SE 0.21, SD 8.8, median 27) (51.4)
respectively. For both scales, Mann Whitney U tests showed that
the differences were significant (p,0.001, p,0.001, N= 3538).
Logistic regression showed that people with a moderate MSIS-29-
PHYS score had odds of 0.25 (CI 0.21, 0.30, p,0.001) of being in
paid work, and for the people with a high score the odds were 0.08
(CI 0.06, 0.10, p,0.001), relative to those in the low tertile.
Similarly, for the MSIS-29-PSYCH tertiles the values were 0.58
(CI 0.50, 0.67, p,0.001) and 0.29 (CI 0.24, 0.35, p,0.001),
respectively. These values equate to 4.0 and 12.5 times the odds of
not being in paid work for people with moderate and high MSIS-
29-PHYS scores compared to those with low scores, and 1.7 and
3.5 times the odds for people with moderate and high MSIS-29-
PSYCH scores, respectively.
Table 2. Frequencies of low, moderate and high MSIS-29
scores among the cohort.
Category MSIS-29-PHYS
Low Moderate High Total
(Lower
tertile)
(Middle
tertile)
(Upper
tertile)
All: No. (in each tertile)1380 1720 1458 4558
% (in each tertile) 30.3 37.7 32.0 100.0
Type of MS
PPMS: No. 87 274 298 659
% 13.2 41.6 45.2 100.0
RRMS: No. 1035 1000 734 2769
% 37.4 36.1 26.5 100.0
SPMS: No. 21 154 187 362
% 5.8 42.5 51.7 100.0
DKMS: No. 212 251 209 672
% 31.5 37.4 31.1 100.0
MSIS-29-PSYCH
All: No. 1634 1840 884 4558
% 40.2 40.4 19.4 100.0
Type of MS
PPMS: No. 266 266 127 659
% 40.4 40.4 19.2 100.0
RRMS: No. 1127 1106 536 2769
% 40.7 39.9 19.4 100.0
SPMS: No. 125 161 76 362
% 34.5 44.5 21.0 100.0
DKMS: No. 278 267 127 672
% 41.4 39.7 18.9 100.0
MSIS-29-PHYS
MSIS-29-PSYCH
Low: No. 1009 614 211 1834
% 55.0 33.5 11.5 100.0
Moderate: No. 342 840 658 1840
% 18.6 45.6 35.8 100.0
High: No. 29 266 589 884
% 3.3 30.1 66.6 100.0
doi:10.1371/journal.pone.0055422.t002
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Discussion
Main findings
This study has examined the physical and psychological impact
of MS using .4500 responses to the MSIS-29 via the web portal
of the UK MS Register. This scale has been found to be reliable
and valid for use in research and clinical settings and our findings
using data collected via a web portal are consistent with the
reported properties of the scale [2,4,5,7]. This is encouraging and
supports the feasibility of using this method as an alternative mode
of data collection to collect patient reported outcome data, such as
these, in research studies and clinical trials [12]. Our cohort
displayed a broad range of ages and MS durations, and was
reasonably representative of many of the characteristics of other
prevalent MS cohorts [20–23]. The mean MSIS-29-PHYS and
MSIS-29-PSYCH scores were similar to those reported elsewhere
(56.0% and 45.5% respectively, N=703) [2]. Since the MSIS-29-
PHYS scale runs from 20 to 100, and MSIS-29-PSYCH from 9 to
45, we have reported the raw scores and percentages based on
transformed data for ease of reference. There is some evidence to
indicate that the MSIS-29-PHYS and MSIS-29-PSYCH scales are
measuring related but distinct constructs and so the use of a
combined score was not recommended as it may mask important
differential effects on physical and psychological health [2]. Our
results concur with this as it was found that MSIS-29-PHYS scores
were positively correlated with age, whereas there was a negative
relationship between MSIS-29-PSYCH scores and age. Further-
more in our previous study using responses to the HADS, we
found a weak negative relationship between age and anxiety, and
differences in depression levels among different age groups [16].
There was a moderately strong positive relationship between the
MSIS-29-PHYS and MSIS-29-PSYCH, and an examination of
frequencies within tertiles showed people with a low MSIS-29-
PHYS score tended to have a low MSIS-29-PSYCH score. This
was also true for people with moderate scores, and of the people
with high MSIS-29-PHYS scores, two-thirds also had high MSIS-
29-PSYCH scores. The converse was also true with only low
proportions of people having a low or a high score on both scales.
These findings further support the relationship between the scales
and the importance of jointly, but separately, considering physical
and psychological impacts on people with MS. There were
differences in the MSIS-29-PHYS and MSIS-29-PSYCH scores
depending on the type of MS: people with PPMS or SPMS had
higher MSIS-29-PHYS scores than people with RRMS, and
people with SPMS had the highest MSIS-29-PSYCH scores. This
would be expected due to the variable disease course in different
types of MS.
During their validation of the scale, Hobart and colleagues
found that people who had retired (N= 390) because of their MS
had higher mean MSIS-29-PHYS and MSIS-29-PSYCH scores
than those who were in employment (N=107) [2]. With a much
larger sample, we have been able to study the impact of MS on the
potential workforce in greater depth, including how predictive the
scores are of a person being unable to work. We showed that a
greater proportion of people with MS report that they are sick/
disabled compared to the general UK workforce, and fewer are in
Figure 2. The MSIS-29-PHYS scores by type of MS. The relative MSIS-29-PHYS scores of people who report having different types of MS are
indicated.
doi:10.1371/journal.pone.0055422.g002
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gainful employment [19]. Furthermore, the MSIS-29-PHYS and
MSIS-29-PSYCH scores for the sick/disabled group were
significantly higher than the remainder of the cohort, and people
with higher scores had higher odds of having a status of sick/
disabled. This relationship was demonstrated with MSIS-29-
PHYS and MSIS-29-PSYCH in tertiles and, since MSIS-29-
PHYS scores were the stronger predictor of sick/disability status, it
was also shown for this scale divided into bands of 10 and clear
incremental increases in the likelihood of people reporting sick/
disabled as their employment status were observed. This may be
useful to clinicians in assessing people’s likely opportunities to be in
employment, and we suggest this also reasonably represents a
proxy for assessing impact on engaging in general life activities.
We chose to use the relationship between MSIS-29 scores and
being sick/disabled to assess impact, rather than between MSIS-
29 scores and being in paid work, as there may be various reasons
why a person may or may not actually be in employment. These
include personal circumstances, choices and needs, and the
unavailability of work. Nevertheless, we found that the MSIS-
29-PHYS and MSIS-29-PSYCH scores were significantly lower
among those in paid work compared to the remainder of the
cohort, and people with moderate or high MSIS-29-PHYS and
MSIS-29-PSYCH scores showed significantly decreased odds of
being in paid work. As would be expected, the effects are not as
large as found using sick/disabled status as the predicted outcome.
But this indicates not only that disability due to MS (as measured
by MSIS-29 scores) is strongly predictive of being sick/disabled,
but it is also a major factor in why people are not actually taking
an active part in the workforce.
What this study adds
This is the largest known study to look at the impact of MS via
the MSIS-29, and as such it may be of value for comparative
purposes in studies where large numbers are not accessible. Studies
using the scale in different settings were recommended by Hobart
and colleagues [2], and by comparing the internal properties of the
scale with published findings, we have shown that it can be used to
collect data for research via an internet-based web portal. This
study has provided new information on disability in MS directly
from the people with the condition, and it has shown how physical
and psychological disability levels vary with type of MS and with
age and disease duration. The findings examining MSIS-29-PHYS
and MSIS-29-PSYCH scores against age confirmed the suggested
guidance provided by Hobart and colleagues [2] that the MSIS-29
should be used as physical and psychological sub-scales, not as a
combined score. We found that increasing disability scores,
especially on the physical scale, are strongly predictive of the
potential workforce having an employment status of sick/disabled.
We have also shown the increasing odds of a sick/disabled status
based on MSIS-29-PHYS in 10-score bands. This may be useful to
clinicians in estimating the impact of MS on people of workforce
age, and may also be used to represent a proxy measure for
gauging the likely impact of MS on life in general.
Figure 3. The MSIS-29-PSYCH scores by type of MS. The relative MSIS-29-PSYCH scores of people who report having different types of MS are
indicated.
doi:10.1371/journal.pone.0055422.g003
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Figure 4. The MSIS-29-PHYS scores for people of workforce age. The scores of people who report they are sick/disabled ( = 1) were
compared with those who are not sick/disabled ( = 0).
doi:10.1371/journal.pone.0055422.g004
Figure 5. The MSIS-29-PSYCH scores for people of workforce age. The scores of people who report they are sick/disabled ( = 1) were
compared with those who are not sick/disabled ( = 0).
doi:10.1371/journal.pone.0055422.g005
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Limitations
This study was based on self-reported information and it is
possible that the respondents were not necessarily a fully
representative sample of people with MS in the UK. It has been
reported that data may be skewed when using web-based data
collection methods, as the technology may pose a barrier to the
elderly, disadvantaged, technically inexperienced or cognitively
impaired [24,25].However, we have found that the education
profile our cohort is similar to the UK population, and many of
their MS characteristics are typical of other MS prevalent
populations, but our proportion of people with SPMS is lower
than might be expected [11] The reasons for this are not known at
this stage, but they may be partly because half to two-thirds of
people initially diagnosed with RRMS go on to develop SPMS
within 10 to 15 years, and some of the respondents may be
reporting an earlier diagnosis [23,26]. We will be able to estimate
and address any response bias in portal data using the linkable
data from clinical sites and routine sources, as these data accrue.
The MSIS-29 scale has been shown to be useful in measuring the
impact of MS, but we have observed some limitations. For
example, unlike the HADS, it cannot clearly distinguish between
depression and anxiety, and as such, its psychological component
appears to be of more limited value in guiding clinical care. The
UK MS Register is still in its early stages, with further work
underway. Although many studies will be made possible as the
data increase over time, others will still require more traditional
settings and data collection methods.
Future work
We have a programme of further work underway and plan to
analyse the other questionnaires delivered via the platform. These
will include the EQ-5D which is used to assess health status for
clinical and economic evaluation [15], and questionnaires
collecting information on medication records and symptoms. We
plan to re-examine the MSIS-29 in conjunction with reported
symptoms and medication records to determine their patterns in
relation to disability scores. We have recently updated to version 2
of the MSIS-29, including the walking scale and, as data accrue,
we will be able to compare responses to the two versions of the
scale. We are also carrying out qualitative research to ensure that
the Register meets the needs of people with MS [27,28]. As
Register data continue to be collected, we will link self-reported
information with clinical and administrative data to compare
information between the data sources and to enable more in-depth
studies, only possible via data linkage at the individual level.
Conclusion
It is well-known that MS results in numerous, varied disabling
effects and has a major impact on many aspects of life. The MSIS-
29 has been proven to be a reliable and valuable tool for use in MS
care [5,9] and the findings of this novel large-scale study, with data
collection via an internet-based questionnaire delivery platform,
are consistent with this. Our findings support the use of the MSIS-
29 as two sub-scales, one for physical effects and one for
psychological effects, not as a combined score. MSIS-29 scores
can be used to gauge the impact of MS on the potential workforce:
the physical and psychological scores can be used to predict the
odds of people having an employment status of sick/disabled, with
MSIS-29-PHYS scores showing the strongest effect. Our results
underline the importance of using a reliable disease-specific scale
such as the MSIS-29 for regular monitoring of people with MS to
help them take an active part in the workforce and in the
enjoyment of general life activities.
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Figure 6. Odds ratios of the workforce being sick/disabled. Logistic regression was conducted to predict the odds of members of the
workforce being sick/disabled based on their MSIS-29-PHYS scores in bands of 10 (above the minimum score of 20), relative to the lowest band (up
30). The upper and lower confidence intervals are indicated by vertical lines.
doi:10.1371/journal.pone.0055422.g006
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